Direkt zum Inhalt
Merck

The newer direct oral anticoagulants: a practical guide.

Clinical medicine (London, England) (2014-04-10)
Jecko Thachil
ZUSAMMENFASSUNG

Anticoagulation therapy is one of the most important advances in modern medicine, saving thousands of lives from the complications of atrial fibrillation and mechanical heart valves and preventing recurrent venous thromboembolism. Warfarin and heparins have been the predominant anticoagulants used until the past decade. However, the arrival of newer target-specific anticoagulants has brought us easier and equally effective agents, although no specific antidotes are yet available. Being relatively newer drugs, physicians need to be familiar with the various practical issues that may be encountered with the prescription of these drugs, which are summarised in this review.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
β-Alanin, 99%
Supelco
Warfarin, PESTANAL®, analytical standard
Supelco
Warfarin, analytical standard
Sigma-Aldrich
β-Alanin, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
β-Alanin, BioXtra, ≥99.0% (NT)
Supelco
β-Alanin, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
β-Alanin, analytical standard
Sigma-Aldrich
β-Alanin, BioUltra, ≥99.0% (NT)